Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Products labeled for research use are not approved for human consumption, and they are not regulated the same way as prescription medications
Because retatrutide remains unlicensed, its full side-effect profile has not been formally established through post-marketing surveillance
Common injection site problems and solutions Even with perfect technique, injection site issues occasionally develop
Where to Buy & Cost Research suppliers: Peptide Sciences, Orovia Biolab, Limitless Biotech, or SwissChems (~$50-100 for 10 x 10mg capsules)
Thinning skin, vasculitis, purpuric dermatosis, platelet deficiency, liver disease, vitamin K deficiency, vitamin C deficiency, moving your body during the injection, or dehydration may also cause bruising
The compound is a potent dual agonist on hMC3R (EC 50 = 0.073 nM, E max = 96%) and hMC4R (EC 50 = 0.042 nM, E max = 101%) ( This novel approach to melanocortin receptor selectivity for weight loss was informed by our previous work demonstrating that co-administration of an MC4R-selective agonist and an MC3R-selective agonist caused a greater reduction in food intake and body weight in DIO NHPs than administration of either compound alone, yielding 7.8% weight loss after 36 days ( The role of dual agonism is further emphasized by 710GO, which displays agonist activity on both MC3R and MC4R
